Latest filing published 16 Jun 2022 for AdaptHealth Corp., €1,623.
Filing timeline
BuySaleInsider track record
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
SkyKnight Capital, L.P.: trading record in brief
SkyKnight Capital, L.P. discloses dealings in AdaptHealth Corp. to SEC (Form 4). We count 2 filings, every one of them for a trade on 14 June 2022.
Every open-market trade on record is a purchase: 2 purchases worth €1.6M, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 16 June 2022 came the latest disclosure, an open-market purchase for €1.6M in AdaptHealth Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to SkyKnight Capital, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 100 shares@ US$16.95100.0% of flowCommon StockSEC:0000899243-22-022818:0Canonical exit: 12 Sept 2022 (T+90)
1 of 1 declaration
